Oxurion Nv Aktie - 0G99

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

48.800,00

Gebot

0,00

Fragen

0,00

Volumen

0,00

0,00 Tagesbereich 0,00

48.800,00 52-Wochen-Bereich 48.800,00

Marktkapitalisierung

170,286T

Handelsende

48.800,00

Handelsbeginn

Letzte Trade

(O)

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

3.489.459.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-27,78

Gewinn pro Aktie (EPS)

-0,01

Erlöse

154k

Nettogewinn

-18,97M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.oxurion.com

Hauptsitz

Leuven, Flemish Brabant, Bel

Gegründet

Oxurion Nv is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker 0G99. The last closing price for Oxurion Nv was 48.800,00 €. Over the last year, Oxurion Nv shares have traded in a share price range of 48.800,00 € to 48.800,00 €.

Oxurion Nv currently has 3.489.459.000 shares in issue. The market capitalisation of Oxurion Nv is 170,29 € trillion. Oxurion Nv has a price to earnings ratio (PE ratio) of -27.78.

Oxurion Share Consolidation

Oxurion Share Consolidation Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the...

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Oxurion Announces Results on the Extraordinary General...

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Information on the Total Number of Voting...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special...

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Oxurion provides...

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production...

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024 Oxurion...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	48800	48800	48800	0	0	DE
4	48800	48800	48800	0	0	DE
12	48800	48800	48800	14	48800	DE
26	48800	48800	48800	7	48800	DE
52	48800	48800	48800	3083	48800	DE
156	48800	48800	48800	138495	48800	DE
260	48800	48800	48800	83262	48800	DE

0G99 - Frequently Asked Questions (FAQ)

What is the current Oxurion Nv share price?

The current share price of Oxurion Nv is 48.800,00 €

How many Oxurion Nv shares are in issue?

Oxurion Nv has 3.489.459.000 shares in issue

What is the market cap of Oxurion Nv?

The market capitalisation of Oxurion Nv is EUR 170,29T

What is the 1 year trading range for Oxurion Nv share price?

Oxurion Nv has traded in the range of 48.800,00 € to 48.800,00 € during the past year

What is the PE ratio of Oxurion Nv?

The price to earnings ratio of Oxurion Nv is -27,78

What is the reporting currency for Oxurion Nv?

Oxurion Nv reports financial results in EUR

What is the latest annual turnover for Oxurion Nv?

The latest annual turnover of Oxurion Nv is EUR 154k

What is the latest annual profit for Oxurion Nv?

The latest annual profit of Oxurion Nv is EUR -18,97M

What is the registered address of Oxurion Nv?

The registered address for Oxurion Nv is GASTON GEENSLAAN 1, LEUVEN, FLEMISH BRABANT, B-3001

What is the Oxurion Nv website address?

The website address for Oxurion Nv is www.oxurion.com

Which industry sector does Oxurion Nv operate in?

Oxurion Nv operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CMOCmo Group Plc	10,75p (207,14%)	539,35k
URUUru Metals Limited	10,00p (33,33%)	401,92k
UFOAlien Metals Limited	0,1025p (20,59%)	418,93M
JADEJade Road Investments Limited	0,315p (18,87%)	3,33M
LIFSLifesafe Holdings Plc	8,50p (17,24%)	65,77k
EMHEuropean Metals Holdings Limited	15,00p (-31,82%)	6,54M
MET1Metals One Plc	7,50p (-30,23%)	348,84k
TRCThe Revel Collective Plc	0,175p (-22,22%)	18,39M
AAUAriana Resources Plc	1,40p (-20,00%)	10,41M
RMRRome Resources Plc	0,15p (-18,92%)	8,97M
PREMPremier African Minerals Limited	0,01425p (-10,94%)	1,33B
TRPTower Resources Plc	0,0295p (-6,35%)	475,04M
UFOAlien Metals Limited	0,1025p (20,59%)	416,23M
EMEEmpyrean Energy Plc	0,1425p (14,00%)	405,92M
SYMESupply@me Capital Plc	0,004p (11,11%)	206,85M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Oxurion Nv (0G99)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Oxurion Nv

0G99 Neueste Nachrichten

Oxurion Share Consolidation

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Announces Extraordinary General Shareholders’ Meeting

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Share Consolidation

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

0G99 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Oxurion Nv (0G99) Börsenkurse

Oxurion Nv (0G99)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Oxurion Nv

0G99 Neueste Nachrichten

Oxurion Share Consolidation

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Announces Extraordinary General Shareholders’ Meeting

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Share Consolidation

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

0G99 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen